- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Middle temporal artery.
Displaying page 1 of 1.
EudraCT Number: 2011-003470-88 | Sponsor Protocol Number: 11-195 | Start Date*: 2012-07-30 | ||||||||||||||||
Sponsor Name:University Medical Center Utrecht, The Netherlands | ||||||||||||||||||
Full Title: Phenylephrine versus EPhedrine on cerebral Perfusion during carotid EndarteRectomy: PEPPER study | ||||||||||||||||||
Medical condition: Hypotension during carotid endarterectomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008713-20 | Sponsor Protocol Number: BGC20-1531-04 | Start Date*: 2009-03-26 |
Sponsor Name:Danish Headache Center | ||
Full Title: EP4 receptor antagonism and PGE2 in a human headache model | ||
Medical condition: PGE2 will induce headache in healthy subjects and BGC20-1531 or placebo will be used to block the developement of headache. In the future BGC20-1531 might be a possible anti-migraine drug. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-003870-27 | Sponsor Protocol Number: RA2363 | Start Date*: 2008-10-08 |
Sponsor Name:University of Nottingham | ||
Full Title: ENOS: Efficacy of Nitric Oxide in Stroke. Estudio ENOS: Eficacia del óxido nítrico en el ictus | ||
Medical condition: Hipertensión en el ictus agudo | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) DK (Completed) SE (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-000815-13 | Sponsor Protocol Number: DIA-644-HOL-005-I | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Technical University Munich | |||||||||||||
Full Title: Analysis of cerebral, renal, peripheral, and retinal hemodynamics in adults with type 2 diabetes before, during, and after administration of pioglitazone or placebo. | |||||||||||||
Medical condition: Considering the existing data, Actos (pioglitazone) is a promising candidate to improve hemodynamics of various vascular beds by positive effects on endothelial function. This study aims to analyse... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
